Bernstein Cuts Hospira (HSP) to Market Perform
Tweet
Share
E-mailGet Alerts HSP Hot Sheet
Price: $89.95 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 41
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 41
Join SI Premium – FREE
Hospira (NYSE: HSP) shares are outperforming the broader stock market Monday despite being downgraded from Outperform to Market Perform at Bernstein earlier. The firm's price target was lowered from $36 to $32.
With shares of Hospira last trading at $29.06, up about 0.5 percent from Friday's closing price, Bernstein's new price target still implies potential upside of about 10 percent.
For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.
With shares of Hospira last trading at $29.06, up about 0.5 percent from Friday's closing price, Bernstein's new price target still implies potential upside of about 10 percent.
For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Downgrades Marinus Pharmaceuticals (MRNS) to Neutral, 'Phase 3 RAISE Study Doesn't Hit at Interim'
- Morgan Stanley Downgrades Integral Ad Science Holding Corp (IAS) to Equalweight
- HSBC Upgrades AMD (AMD) to Buy, 'AI TAM more than enough to go around'
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
